2025年人工智慧（AI）病理品管全球市场报告

近年来，人工智慧（AI）病理品管市场发展迅速，预计从2024年的14.6亿美元成长到2025年的17.8亿美元，复合年增长率（CAGR）为21.6%。这段时期推动市场成长的主要因素包括癌症和慢性病盛行率的上升、对诊断准确性的需求不断增长、熟练病理学家短缺、医疗保健支出增加以及个人化医疗的发展。

预计未来几年，人工智慧（AI）病理品管市场将呈指数级增长，到2029年市场规模将达到38.4亿美元，复合年增长率（CAGR）为21.2%。预测期内的成长主要受以下因素驱动：对自动化品质保证的需求不断增长、对医疗保健AI新兴企业的投资增加、云端基础病理解决方案的普及、精准医疗倡议的扩展以及对早期疾病检测的日益重视。这段时期的关键趋势包括：深度学习演算法的进步、品质控制自动化工具的创新、数位病理平台与人工智慧的融合、云端基础病理系统的开发以及多模态诊断分析的进步。

个人化医疗需求的不断增长预计将推动人工智慧（AI）病理品管市场的扩张。个人化医疗是指根据个人的基因组成、生活方式和环境因素来制定个人化的治疗和预防策略。个人化医疗的广泛应用主要归功于基因组学的进步，这使得基因突变的识别更加精准，并促进了标靶治疗的开发。人工智慧驱动的病理品管透过提供准确一致的诊断资讯来增强个人化医疗，并有助于制定个人化的治疗方案。自动化品质检查可以最大限度地减少诊断错误，提高准确性和可靠性，并推动个人化医疗的发展。例如，美国非营利组织个人化医疗联盟（PMC）报告称，美国食品药物管理局（FDA）在2023年核准了26种个人化新药，较2022年的12种显着增加。这种对个人化医疗日益增长的需求预计将推动人工智慧病理品管市场的发展。

人工智慧（AI）病理品管市场的关键参与者正致力于开发先进的解决方案，例如人工智慧驱动的技术，以提高诊断准确性、简化检查室工作流程并确保病理数据的可靠性。这些新一代人工智慧解决方案能够执行复杂的任务，同时提高速度、准确性和效率。例如，总部位于美国的生物技术公司PathAI于2023年11月在其AISight数位病理平台上推出了Artifact Detect 1。该工具可自动侦测并量化全切片影像（WSI）中的伪影。透过自动筛检切片中的品质问题，Artifact Detect可防止误诊和不必要的重复扫描，从而提高准确性、检查室效率和整体吞吐量。它还能及时采取纠正措施，例如重新染色和重新扫描，从而改善数位化工作流程并节省病理学家和技术人员的资源。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球人工智慧（AI）病理品管：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 终端用户产业分析
• 全球人工智慧（AI）病理品管市场：成长率分析
• 全球人工智慧（AI）病理品管市场表现：规模与成长，2019-2024年
• 全球人工智慧（AI）病理品管市场预测：规模与成长，2024-2029年，2034年
• 全球人工智慧（AI）病理品管：潜在市场规模（TAM）

第六章 市场细分

• 全球人工智慧（AI）病理品管市场：按组件、性能和预测划分，2019-2024年、2024-2029年、2034年
• 软体
• 硬体
• 服务
• 全球人工智慧（AI）病理品管市场：按部署模式、性能和预测划分，2019-2024年、2024-2029年、2034年
• 本地部署
• 云端基础的
• 全球人工智慧（AI）病理品管市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
• 癌症诊断
• 感染疾病诊断
• 数位病理学
• 研究
• 其他用途
• 全球人工智慧（AI）病理品管市场按最终用户、性能和预测划分，2019-2024年、2024-2029年、2034年
• 医院
• 诊断实验室
• 研究所
• 製药和生物技术公司
• 其他最终用户
• 全球人工智慧（AI）病理品管市场：按软体、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
• 影像分析软体
• 诊断决策支援软体
• 工作流程管理软体
• 彙报和视觉化软体
• 全球人工智慧（AI）病理品管市场：按硬体、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
• 数位病理扫描仪
• 影像设备
• 伺服器和储存系统
• 实验室设备
• 全球人工智慧（AI）病理品管市场：按服务、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
• 实施服务
• 培训和支援服务
• 维护和升级服务
• 咨询服务

第七章 区域和国家分析

• 全球人工智慧（AI）病理品管市场按地区、业绩和预测划分，2019-2024年、2024-2029年、2034年
• 全球人工智慧（AI）病理品管市场：国家、绩效与预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

• 人工智慧（AI）病理品管市场：竞争格局
• 人工智慧（AI）病理品管市场：公司概况
  • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Clinisys Group Ltd.
• Sectra AB
• PathAI Inc.
• OptraSCAN Inc.
• Paige.AI Inc.
• Proscia Inc.
• Quibim SL
• 3DHISTECH Ltd.
• Visiopharm A/S
• Indica Labs Inc.
• Ibex Medical Analytics Ltd.
• Aiosyn BV
• DeepBio Inc.
• Nucleai Ltd.
• Gestalt Diagnostics LLC

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

• 2029年人工智慧（AI）病理品管市场：提供新机会的国家
• 2029年人工智慧（AI）病理品管市场：新兴细分市场机会
• 2029年人工智慧（AI）病理品管市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章附录

Artificial intelligence (AI) pathology quality control involves using AI algorithms and machine learning models to automatically evaluate and ensure the accuracy, consistency, and reliability of pathology data and slide interpretations. Its primary goal is to identify errors, standardize analyses, and enhance diagnostic precision in histopathology and cytopathology workflows, ultimately improving patient outcomes.

The main components of AI pathology quality control include software, hardware, and services. The software consists of AI-driven platforms and applications for automated analysis, quality assessment, and error detection in pathology workflows. These solutions can be deployed on-premises or via cloud-based systems. Applications include cancer diagnostics, infectious disease detection, digital pathology, research, and related areas, serving hospitals, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and other key end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI) pathology quality control market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) pathology quality control market statistics, including the artificial intelligence (AI) pathology quality control industry global market size, regional shares, competitors with the artificial intelligence (AI) pathology quality control market share, detailed artificial intelligence (AI) pathology quality control market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) pathology quality control industry. This artificial intelligence (AI) pathology quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) pathology quality control market size has grown exponentially in recent years. It will grow from $1.46 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 21.6%. The growth during the historic period is driven by rising prevalence of cancer and chronic diseases, increasing demand for diagnostic accuracy, shortage of skilled pathologists, higher healthcare expenditure, and growth of personalized medicine.

The artificial intelligence (AI) pathology quality control market size is expected to see exponential growth in the next few years. It will grow to $3.84 billion in 2029 at a compound annual growth rate (CAGR) of 21.2%. The projected growth in the forecast period is supported by rising demand for automated quality assurance, increasing investment in healthcare AI startups, adoption of cloud-based pathology solutions, expansion of precision medicine initiatives, and greater focus on early disease detection. Key trends in this period include advancements in deep learning algorithms, innovations in QC automation tools, integration of AI with digital pathology platforms, development of cloud-based pathology systems, and progress in multimodal diagnostic analytics.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) pathology quality control market. Personalized medicine involves tailoring treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environmental factors. The rise in personalized medicine adoption is largely attributed to advancements in genomics, which enable more precise identification of genetic variations and the development of targeted treatments. AI-powered pathology quality control enhances personalized medicine by offering accurate and consistent diagnostic insights, facilitating the creation of individualized treatment plans. It minimizes diagnostic errors by automating quality checks, improving accuracy and reliability, and advancing patient-specific care. For example, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from 12 in 2022. This growing demand for personalized medicine is expected to propel the AI pathology quality control market.

Key players in the artificial intelligence (AI) pathology quality control market are focusing on developing advanced solutions, such as AI-powered technologies, to enhance diagnostic precision, streamline laboratory workflows, and ensure the reliability of pathology data. These next-generation AI solutions perform complex tasks with improved speed, accuracy, and efficiency. For instance, in November 2023, PathAI, a US-based biotechnology company, introduced Artifact Detect 1 on its AISight digital pathology platform. This tool automates the detection and quantification of artifacts in whole slide images (WSI), which are non-relevant features that can reduce diagnostic accuracy. ArtifactDetect helps prevent misdiagnoses and unnecessary rescans by automatically screening slides for quality issues, boosting accuracy, laboratory efficiency, and overall throughput. It enables timely corrective actions, such as re-staining or re-scanning, improving digital workflows and conserving resources for pathologists and technicians.

In November 2024, Molbio Diagnostics Pvt. Ltd., an India-based molecular diagnostics company, acquired a majority stake in OptraSCAN Inc. through a $30 million investment. This acquisition enables Molbio to expand its presence in digital and AI-driven pathology, broaden its diagnostic portfolio beyond molecular testing, enhance its global market reach, and accelerate innovation in pathology quality control and precision diagnostics. OptraSCAN Inc., based in the US, provides AI solutions for pathology quality control as part of its digital pathology offerings.

Major players in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., and Gestalt Diagnostics LLC.

North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) pathology quality control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI) pathology quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) pathology quality control market consists of revenues earned by entities by providing services such as automated slide review, error detection in pathology reports, consistency checks in histopathology and cytopathology analyses, digital image analysis, workflow optimization, and validation of diagnostic results using AI-powered tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) pathology quality control market also includes sales of artificial intelligence (AI)-powered pathology software, digital pathology platforms, image analysis tools, and quality assurance modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Pathology Quality Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) pathology quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) pathology quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) pathology quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Deployment Mode: On-Premises; Cloud-Based
• 3) By Application: Cancer Diagnostics; Infectious Disease Diagnostics; Digital Pathology; Research; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Software: Image Analysis Software; Diagnostic Decision Support Software; Workflow Management Software; Reporting And Visualization Software
• 2) By Hardware: Digital Pathology Scanners; Imaging Devices; Servers And Storage Systems; Laboratory Equipment
• 3) By Services: Implementation Services; Training And Support Services; Maintenance And Upgrade Services; Consulting Services
• Companies Mentioned: Roche Diagnostics GmbH; Danaher Corporation; Philips Healthcare; Agilent Technologies Inc.; Hologic Inc.; Clinisys Group Ltd.; Sectra AB; PathAI Inc.; OptraSCAN Inc.; Paige.AI Inc.; Proscia Inc.; Quibim S.L.; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Aiosyn B.V.; DeepBio Inc.; Nucleai Ltd.; Gestalt Diagnostics LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) Pathology Quality Control Market Characteristics

3. Artificial Intelligence (AI) Pathology Quality Control Market Trends And Strategies

4. Artificial Intelligence (AI) Pathology Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) Pathology Quality Control Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI) Pathology Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI) Pathology Quality Control Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI) Pathology Quality Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI) Pathology Quality Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI) Pathology Quality Control Total Addressable Market (TAM)

6. Artificial Intelligence (AI) Pathology Quality Control Market Segmentation

• 6.1. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• Services
• 6.2. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-Premises
• Cloud-Based
• 6.3. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Diagnostics
• Infectious Disease Diagnostics
• Digital Pathology
• Research
• Other Applications
• 6.4. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.5. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Image Analysis Software
• Diagnostic Decision Support Software
• Workflow Management Software
• Reporting And Visualization Software
• 6.6. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Pathology Scanners
• Imaging Devices
• Servers And Storage Systems
• Laboratory Equipment
• 6.7. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implementation Services
• Training And Support Services
• Maintenance And Upgrade Services
• Consulting Services

7. Artificial Intelligence (AI) Pathology Quality Control Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI) Pathology Quality Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI) Pathology Quality Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market

• 8.1. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) Pathology Quality Control Market

• 9.1. China Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 9.2. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) Pathology Quality Control Market

• 10.1. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) Pathology Quality Control Market

• 11.1. Japan Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 11.2. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) Pathology Quality Control Market

• 12.1. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market

• 13.1. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) Pathology Quality Control Market

• 14.1. South Korea Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 14.2. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market

• 15.1. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 15.2. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) Pathology Quality Control Market

• 16.1. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) Pathology Quality Control Market

• 17.1. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) Pathology Quality Control Market

• 18.1. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) Pathology Quality Control Market

• 19.1. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) Pathology Quality Control Market

• 20.1. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market

• 21.1. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) Pathology Quality Control Market

• 22.1. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) Pathology Quality Control Market

• 23.1. North America Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 23.2. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) Pathology Quality Control Market

• 24.1. USA Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 24.2. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) Pathology Quality Control Market

• 25.1. Canada Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 25.2. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) Pathology Quality Control Market

• 26.1. South America Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 26.2. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) Pathology Quality Control Market

• 27.1. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) Pathology Quality Control Market

• 28.1. Middle East Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 28.2. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) Pathology Quality Control Market

• 29.1. Africa Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 29.2. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) Pathology Quality Control Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI) Pathology Quality Control Market Competitive Landscape
• 30.2. Artificial Intelligence (AI) Pathology Quality Control Market Company Profiles
  • 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) Pathology Quality Control Market Other Major And Innovative Companies

• 31.1. Clinisys Group Ltd.
• 31.2. Sectra AB
• 31.3. PathAI Inc.
• 31.4. OptraSCAN Inc.
• 31.5. Paige.AI Inc.
• 31.6. Proscia Inc.
• 31.7. Quibim S.L.
• 31.8. 3DHISTECH Ltd.
• 31.9. Visiopharm A/S
• 31.10. Indica Labs Inc.
• 31.11. Ibex Medical Analytics Ltd.
• 31.12. Aiosyn B.V.
• 31.13. DeepBio Inc.
• 31.14. Nucleai Ltd.
• 31.15. Gestalt Diagnostics LLC

32. Global Artificial Intelligence (AI) Pathology Quality Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Pathology Quality Control Market

34. Recent Developments In The Artificial Intelligence (AI) Pathology Quality Control Market

35. Artificial Intelligence (AI) Pathology Quality Control Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer